Hormone therapy has been misunderstood since 2002.
A single early-stopped trial — using synthetic hormones, in women mostly over 60 — reshaped how an entire generation of doctors was taught to think about menopause. Bioidentical hormones weren't what was studied, but they're often what gets denied because of it. It's time that got untangled, one patient at a time.
Symptoms That Get Written Off Too Easily
These often reflect natural, measurable changes in estradiol, progesterone, and testosterone during midlife — not something to just push through.
Sleep Disruption & Night Sweats
Falling or staying asleep gets harder, often tied to shifting progesterone and estradiol.
Brain Fog & Mood Changes
Word-finding, focus, and emotional steadiness can all shift as hormone levels fluctuate.
Weight Gain & Metabolic Shifts
Body composition and where you carry weight can change even without changes in diet or activity.
Declining Libido & Energy
Often tied to testosterone and estradiol decline, and frequently under-discussed in a standard visit.
Changes in Recovery & Resilience
Slower recovery from exercise or illness, and a general sense of reduced physical resilience.
Shifts in Motivation
A flatter drive or motivation that doesn't track with anything else going on in your life.
The WHI Didn't Say What Most Doctors Were Taught
Here's the short version of a much longer story Dr. Juan wrote about — read the full piece linked below.
What Was Studied
The Women's Health Initiative enrolled roughly 161,000 postmenopausal women, most over age 60. The hormone arm tested two synthetic compounds: Conjugated Equine Estrogen (CEE, derived from horse estrogen) and Medroxyprogesterone Acetate (MPA, a synthetic progestin) — not bioidentical hormones.
What Was Published
In 2002, the combined hormone trial was stopped early after data showed increased risk of invasive breast cancer, heart disease, stroke, and blood clots. Women were taken off HRT almost overnight, and medical training on hormone therapy largely stopped.
What Was Overlooked
The study never separated bioidentical hormones from synthetic ones. Oral estrogen and synthetic CEE are both liver-metabolized, which is tied to clotting risk — but transdermal bioidentical estradiol bypasses the liver and doesn't carry that same risk.
The breast cancer signal appears linked specifically to MPA, a synthetic progestin roughly 50 times more potent than bioidentical oral micronized progesterone. Research is ongoing into whether bioidentical progesterone carries meaningfully lower risk — early data suggests it does.
What We Know Now
Progesterone converts to allopregnanolone, a naturally occurring molecule that supports sleep and mood — meaning even women without a uterus, historically told to take estrogen alone, may still benefit from progesterone.
Despite this, a 2026 Mayo Clinic study of insurance claims found systemic HRT use among US women 40+ dropped from 4.4% in 2007 to just 1.7% in 2023 — likely an undercount, since compounded prescriptions aren't captured in claims data.
This is the short version. Dr. Juan wrote the full story of what happened, what was missed, and what it means for you today. Read "The WHI, HRT, and What Got Lost in Translation" →
Three Short Videos on Why This Matters
What sparked this — my wife's own journey into women's health beyond what medical school taught me
The Menopause Rating Scale — a real tool for tracking your symptoms
Hormone care is primary care — not a separate subscription
Estradiol, Progesterone & Testosterone Overlap More Than You'd Think
These three hormones are often discussed in isolation, but their effects overlap significantly — which is exactly why treatment has to be individualized, not templated.
Estradiol
- Cardiovascular health
- Bone density
- Metabolic regulation
- Cognitive & vascular function
Progesterone
- Sleep quality
- Mood
- Uterine protection
Testosterone
- Body composition
- Physical resilience
- Cognition
- Energy & recovery
- Bone density
Where the circles overlap: bone density, cognitive function, energy, and mood are shaped by all three hormones together — which is why a single-hormone approach rarely tells the full story.
Not the Same Medications the WHI Studied
Much of the concern around hormone therapy traces back to early-2000s studies of older estrogen formulations and synthetic progestins, in women many years past menopause. Today's most commonly prescribed options are different:
These behave differently in the body and may offer a more favorable safety profile when prescribed thoughtfully in the right patient. For many healthy women near the onset of menopause, the risks of breast cancer and blood clots have been significantly overstated in public discussion.
A History Doesn't Automatically Rule Hormone Therapy Out
Breast cancer history, clotting history, and family history are real factors to weigh — but none of them automatically take hormone therapy off the table. Each deserves a real conversation about your specific history, not a blanket policy.
Breast Cancer History or Risk
The strongest signal from the WHI traces to a synthetic progestin, not bioidentical hormones. Personal and family history shape — but don't automatically eliminate — the conversation.
Blood Clot Risk
Clot risk is tied specifically to how a hormone is metabolized. Transdermal bioidentical estradiol bypasses the liver and carries a different risk profile than oral formulations.
Family History
Family history informs risk stratification and monitoring — it's a factor to account for, not a reason to close the door before an individualized evaluation.
Hormone Care Is Primary Care
A growing number of online hormone clubs and subscription platforms treat menopause as an isolated prescription to fill. But hormone health doesn't exist in isolation — it intersects with cardiovascular risk, bone density, metabolic health, sleep, and preventive screening, all at once.
Divorcing hormone therapy from the rest of your primary care means the physician managing your estradiol dose may not be the one tracking your lipids, your bone density, or your family history. Your doctor should be able to talk about all of it with you — together, in one relationship.
Hormone Health Is Tied to Thyroid Health
Estrogen, progesterone, and testosterone don't operate independently of thyroid function — perimenopause and thyroid changes often show up on similar timelines, with overlapping symptoms like fatigue, weight changes, and mood shifts. Evaluating one without the other misses part of the picture.
One Physician. One Strategy. Longitudinal Care.
Hormone therapy is never one-size-fits-all. Symptoms, physiology, medical history, and risk factors all shape treatment decisions — and dosing and monitoring evolve as your body changes over time.
Hormone Health Doesn't Stand Alone
Let's Have the Conversation Most Doctors' Training Skipped
If you're navigating perimenopause or menopause and want a thoughtful, physician-led approach to hormone therapy, this starts with a conversation — not a protocol.
Begin the Conversation →*Source: 2026 Mayo Clinic study of US insurance claims data, 2007–2023. Compounded prescriptions are not captured in claims data, so actual use may be higher. All treatment is individualized based on personal history, risk factors, and shared decision-making with your physician.